Director/PDMR Shareholding

RNS Number : 8891Z
IXICO plc
15 January 2020
 

15 January 2020

 

IXICO plc

("IXICO" or the "Company")

 

Exercise of Options and PDMR Dealings

IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that it received notification on 10 January 2020 that John Hall, SVP Corporate Development and PDMR, exercised 75,000 options with an exercise price of 34p.

 

The Company has also received notification on 10 January 2020 that Robin Wolz, SVP Research & Development and PDMR, exercised 83,882 options of which 45,176 were exercisable at 30.5p and 38,706 were exercisable at 34p. The 83,882 shares were sold to a third party at an average price of 87.6p.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

John James Hall

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR (SVP Corporate Development)

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

IXICO plc

b)

 

LEI

 

 

2138005M1F59O6HWSA97

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares in IXICO plc



Identification code

GB00BCLY7L40

 


b)

 

Nature of the transaction

 

 

Exercise of options

c)

 

Price(s) and volume(s)

 

 

 

 


 

Exercise Price(s)

Volume(s)

 


 

34p

75,000

 


 

 

 

 

d)

 

Aggregated information




- Aggregated volume

75,000 shares



- Price

34p



e)

 

Date of the transaction

 

 

10/1/20

f)

 

Place of the transaction

 

 

N/A

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Robin Wolz

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR (SVP Research & Development)

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

IXICO plc

b)

 

LEI

 

 

2138005M1F59O6HWSA97

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares in IXICO plc



Identification code

GB00BCLY7L40

 


b)

 

Nature of the transaction

 

 

Exercise of options

c)

 

Price(s) and volume(s)

 

 

 

 


 

Exercise Price(s)

Volume(s)

 


 

30.5p

45,176

 


 

34p

38,706

 


 

 

 

 

d)

 

Aggregated information




- Aggregated volume

83,882 shares



- Price

32.1p



e)

 

Date of the transaction

 

 

10/1/20

f)

 

Place of the transaction

 

 

N/A

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

 

a)

 

Name

 

 

Robin Wolz

 

 

2

 

Reason for the notification

 

 

a)

 

Position/status

 

 

PDMR (SVP Research & Development)

 

b)

 

Initial notification /Amendment

 

 

Initial notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

 

Name

 

 

IXICO plc

 

b)

 

LEI

 

 

2138005M1F59O6HWSA97

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares in IXICO plc

 



 

Identification code

GB00BCLY7L40

 

 


 

b)

 

Nature of the transaction

 

 

Sale

 

c)

 

Price(s) and volume(s)

 

 

 

 

 


 

Price(s)    Date

Volume(s)

 

 


 

92p            10/1/20

18,395

 

 


 

90p            13/1/20  

18,395

 

 


 

85p            13/1/20

47,092

 

 


 

 

 

 

 

d)

 

Aggregated information


 



 

- Aggregated volume

83,882 shares

 



 

- Price

87.6p

 



 

e)

 

Date of the transaction

 

 

10/1/20 and 13/1/20

 

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

IXICO plc

+44 (0) 20 3763 7498

Giulio Cerroni, Chief Executive Officer


Grant Nash, Chief Financial Officer

 


Cenkos Securities PLC (Nominated adviser and sole broker)

+44 (0) 20 7397 8900

Giles Balleny / Max Gould (Corporate Finance)


Michael F Johnson / Russell Kerr (Sales)




Optimum Strategic Communications

 +44 (0) 203 950 9144

Mary Clark / Supriya Mathur/Manel Mateus


ixico@optimumcomms.com


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBELFFBFLXBBB

Companies

Ixico (IXI)
UK 100

Latest directors dealings